Pictet Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179M Buy
1,102,248
+143,285
+15% +$22M 0.19% 132
2025
Q4
$167M Sell
958,963
-181,864
-16% -$33.2M 0.16% 151
2025
Q3
$164M Sell
1,140,827
-412,801
-27% -$50.6M 0.16% 159
2025
Q2
$156M Sell
1,553,628
-459,701
-23% -$35.1M 0.16% 151
2025
Q1
$154M Buy
2,013,329
+53,611
+3% +$4.1M 0.17% 144
2024
Q4
$135M Buy
1,959,718
+96,377
+5% +$6.94M 0.15% 167
2024
Q3
$136M Buy
1,863,341
+372,206
+25% +$27.5M 0.15% 168
2024
Q2
$99.9M Sell
1,491,135
-38,873
-3% -$1.51M 0.11% 189
2024
Q1
$41.5M Sell
1,530,008
-431,793
-22% -$12.1M 0.05% 346
2023
Q4
$60.8M Sell
1,961,801
-451,637
-19% -$11.7M 0.07% 270
2023
Q3
$60.9M Buy
+2,413,438
New +$55.2M 0.08% 261

Other funds holding INSM

Pictet Asset Management's INSM Position: Q1 2026 in Review

Pictet Asset Management increased its Insmed (INSM) stake by 15% in Q1 2026, buying an estimated $22M and bringing the position to 1,102,248 shares worth $179M. The position accounts for 0.19% of the portfolio, ranked #132.

Pictet Asset Management first reported a position in INSM in Q3 2023 and has held it in 11 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Pictet Asset Management held 1,102,248 shares of Insmed worth $179M as of Q1 2026.
  • Pictet Asset Management bought 143,285 Insmed shares in Q1 2026, an estimated $22M.
  • Insmed made up 0.19% of Pictet Asset Management's portfolio in Q1 2026, its #132 holding.
  • Pictet Asset Management first reported a position in Insmed in Q3 2023 and has held it in 11 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.